No Cover Image

Journal article 18 views 5 downloads

Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19 / Patrick Holford, Anitra C. Carr, Thomas Jovic, Stephen Ali, Iain Whitaker, Paul E. Marik, A. David Smith

Nutrients, Volume: 12, Issue: 12, Start page: 3760

Swansea University Authors: Thomas Jovic, Stephen Ali, Iain Whitaker

  • VOR.nutrients-12-03760-v4.pdf

    PDF | Version of Record

    This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC-BY) Licence.

    Download (5.33MB)

Check full text

DOI (Published version): 10.3390/nu12123760

Abstract

There are limited proven therapies for COVID-19. Vitamin C’s antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19. This lite...

Full description

Published in: Nutrients
ISSN: 2072-6643
Published: MDPI AG 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa57714
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: There are limited proven therapies for COVID-19. Vitamin C’s antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19. This literature review focuses on vitamin C deficiency in respiratory infections, including COVID-19, and the mechanisms of action in infectious disease, including support of the stress response, its role in preventing and treating colds and pneumonia, and its role in treating sepsis and COVID-19. The evidence to date indicates that oral vitamin C (2–8 g/day) may reduce the incidence and duration of respiratory infections and intravenous vitamin C (6–24 g/day) has been shown to reduce mortality, intensive care unit (ICU) and hospital stays, and time on mechanical ventilation for severe respiratory infections. Further trials are urgently warranted. Given the favourable safety profile and low cost of vitamin C, and the frequency of vitamin C deficiency in respiratory infections, it may be worthwhile testing patients’ vitamin C status and treating them accordingly with intravenous administration within ICUs and oral administration in hospitalised persons with COVID-19.
Keywords: COVID-19; SARS-CoV-2; coronavirus; vitamin C; ascorbate; colds; pneumonia; sepsis; immunonutrition; supplementation
College: Swansea University Medical School
Issue: 12
Start Page: 3760